Eli Lilly (Mexico) Today
| LLY Stock | MXN 15,313 64.20 0.42% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Eli Lilly is trading at 15313.00 as of the 25th of November 2024; that is 0.42% down since the beginning of the trading day. The stock's open price was 15377.2. Eli Lilly has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Eli Lilly and are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. ELI LILLY operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. The company has 950.18 M outstanding shares. More on Eli Lilly and
Moving together with Eli Stock
Moving against Eli Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Eli Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Eli Lilly's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Eli Lilly or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | David Ricks |
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
Eli Lilly and (LLY) is traded on Mexican Exchange in Mexico and employs 47 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 6.16 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Eli Lilly's market, we take the total number of its shares issued and multiply it by Eli Lilly's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Eli Lilly operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 950.18 M outstanding shares.
Eli Lilly and has accumulated about 2.2 B in cash with 7.26 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.39.
Check Eli Lilly Probability Of Bankruptcy
Ownership AllocationEli Lilly holds a total of 950.18 Million outstanding shares. The majority of Eli Lilly and outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Eli Lilly to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Eli Lilly. Please pay attention to any change in the institutional holdings of Eli Lilly and as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Eli Ownership Details
Eli Lilly Risk Profiles
Although Eli Lilly's alpha and beta are two of the key measurements used to evaluate Eli Lilly's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.52 | |||
| Standard Deviation | 2.22 | |||
| Variance | 4.94 | |||
| Risk Adjusted Performance | (0.08) |
Eli Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Eli Lilly without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Eli Lilly Corporate Management
Elected by the shareholders, the Eli Lilly's board of directors comprises two types of representatives: Eli Lilly inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Eli. The board's role is to monitor Eli Lilly's management team and ensure that shareholders' interests are well served. Eli Lilly's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Eli Lilly's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alonzo Weems | VP Officer | Profile | |
| Jacob Naarden | CEO VP | Profile | |
| Diogo Rau | VP Officer | Profile | |
| Donald Zakrowski | Chief Fin | Profile | |
| Anat Ashkenazi | VP CFO | Profile |
Additional Tools for Eli Stock Analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.